Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey

Central neuropathic pain is difficult to treat, but delta 9-Tetrahydrocannabinol (delta 9-THC) may be a promising therapeutic agent. We administered in 172 patients on average 7.5 mg delta 9-THC over 7 months. Of these, 48 patients prematurely withdrew due to side effects, insufficient analgesia, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Janet, Schley, Marcus, Casutt, Matthias, Gerber, Helmut, Schuepfer, Guido, Rukwied, Roman, Schleinzer, Wolfgang, Ueberall, Michael, Konrad, Christoph
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925209/
https://www.ncbi.nlm.nih.gov/pubmed/20798872
http://dx.doi.org/10.1155/2009/827290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925209/
https://www.ncbi.nlm.nih.gov/pubmed/20798872
http://dx.doi.org/10.1155/2009/827290

Ejemplares similares